Innovage Holding Quick Ratio (INNV) starting from the fourth quarter 2026 to fourth quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Innovage Holding Corp   (NASDAQ: INNV)

Innovage Holding 's Quick Ratio

INNV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2026, Quick Ratio fell to 0.69 below Innovage Holding Corp average.

Within Medical Equipment & Supplies industry 130 other companies have achieved higher Quick Ratio than Innovage Holding in fourth quarter 2026. While Quick Ratio total ranking has improved so far during the Q4 2026 to 2324, from total ranking in the third quarter 2026 at 2943.

Explain Quick Ratio?
How much Cash & cash equivalents INNV´s has?
What are INNV´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INNV Quick Ratio (Jun 30 2026)
Q4		 (Mar 31 2026)
Q3		 (Dec 31 2025)
Q2		 (Sep 30 2025)
Q1		 (Jun 30 2025)
Q4
Y / Y Current Liabilities Change 23.72 % -13.06 % 18.91 % 5.44 % 18.91 %
Y / Y Cash & cash equivalent Change 33.45 % 36.23 % 3.04 % 27.71 % 3.04 %
Quick Ratio MRQ 0.69 0.71 0.64 0.79 0.64
INNV's Total Ranking # 2324 # 2943 # 2533 # 2843 # 3266
Seq. Current Liabilities Change 4.09 % 18.86 % 19 % -15.97 % -26.86 %
Seq. Cash & cash equivalent Change 1.98 % 30.86 % -3.21 % 3.32 % 4.1 %



Quick Ratio fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 699
Overall Market # 2315


Quick Ratio Statistics
High Average Low
14.71 1.27 0
(Dec 31 2011)   (Sep 30 2014)




Financial Statements
Innovage Holding 's Current Liabilities $ 204 Millions Visit INNV's Balance sheet
Innovage Holding 's Cash & cash equivalent $ 141 Millions Visit INNV's Balance sheet
Source of INNV's Sales Visit INNV's Sales by Geography


Cumulative Innovage Holding 's Quick Ratio

INNV's Quick Ratio for the trailling 12 Months

INNV Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 6.51 % 4.75 % 30.71 % 23.47 % 20.49 %
Y / Y Cash & cash equivalent TTM Growth 25.03 % 17.01 % 8.29 % -8.98 % -22.46 %
Quick Ratio TTM 0.7 0.69 0.61 0.63 0.6
Total Ranking TTM # 2127 # 2662 # 1997 # 2135 # 2152
Seq. Current Liabilities TTM Growth 5.89 % -4.24 % 3.93 % 1.08 % 4.13 %
Seq. Cash & cash equivalent TTM Growth 7.7 % 8.71 % 0.74 % 5.99 % 0.8 %

Quick ratio ranking by company, industry and sector >> Back to INNV Financial Strength Comparisons >> Go to Compare INNV Quick Ratio to its Competitors

On the trailing twelve months basis INNV Cash & cash equivalent grew by 33.45 % in Q4 2026 year on year, faster than Current Liabilities, this led to increase in in Innovage Holding 's Quick Ratio to 0.7, above INNV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Innovage Holding . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending third quarter 2026 at 2842.

Explain Quick Ratio?
How much Cash & cash equivalents INNV´s has?
What are INNV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 903
Within the Market # 2324


trailing twelve months Quick Ratio Statistics
High Average Low
2.47 0.62 0.01
(Dec 31 2021)   (Jun 30 2015)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions

Date modified: 2026-09-18T17:03:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.